Laurel Wealth Advisors LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
Laurel Wealth Advisors LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$2,450
-29.5%
2,5000.0%0.00%0.0%
Q2 2023$3,475
-12.6%
2,5000.0%0.00%0.0%
Q1 2023$3,975
-74.5%
2,5000.0%0.00%
-75.0%
Q4 2022$15,575
-8.4%
2,5000.0%0.00%0.0%
Q3 2022$17,000
+6.2%
2,5000.0%0.00%0.0%
Q2 2022$16,000
+33.3%
2,5000.0%0.00%
+33.3%
Q1 2022$12,000
-7.7%
2,5000.0%0.00%0.0%
Q4 2021$13,000
-56.7%
2,5000.0%0.00%
-57.1%
Q3 2021$30,000
-43.4%
2,5000.0%0.01%
-36.4%
Q2 2021$53,000
-24.3%
2,5000.0%0.01%
-35.3%
Q1 2021$70,000
+7.7%
2,5000.0%0.02%0.0%
Q4 2020$65,000
-36.3%
2,500
-8.8%
0.02%
-43.3%
Q3 2020$102,000
+750.0%
2,740
+1041.7%
0.03%
+650.0%
Q2 2020$12,000
+50.0%
2400.0%0.00%
+33.3%
Q1 2020$8,000
-42.9%
2400.0%0.00%
-25.0%
Q4 2019$14,000
+55.6%
2400.0%0.00%
+33.3%
Q3 2019$9,000
-18.2%
2400.0%0.00%
-25.0%
Q2 2019$11,000
+10.0%
2400.0%0.00%0.0%
Q1 2019$10,000
-9.1%
2400.0%0.00%0.0%
Q4 2018$11,0002400.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2022
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders